I believe such FDA regulations are in place for (1) safety concerns and (2) open label trials for life-threatening illness or large scale trials where the investigator indicates the experimental treatment is likely proving fruitless.
I think a DSMB has to be independent of the sponsor.
Market Data 
Markets 
AI
